Early death and CSF monoamine metabolites in schizophrenia spectrum psychosis

References

• Allebeck P, Varla A, Wistedt B. Suicide and violent death among patients with schizophrenia. Acta Psychiatr Scand 1986;74:43–9.
   PubMed Web of Science ®Google Scholar
• Auquier P, Lancon C, Rouillon F, Lader M. Mortality in schizophrenia. Pharmacoepidemiol Drug Saf 2007;16:1308–12.
   PubMed Web of Science ®Google Scholar
• Brown S. Excess mortality of schizophrenia. A meta-analysis. J Clin Psychiatry 1997;171:502–8.
   Google Scholar
• Ösby U, Correia N, Brandt L, Ekbom A, Sparen P. Mortality and causes of death in schizophrenia in Stockholm county, Sweden. Schizophr Res 2000;45:21–8.
   PubMed Web of Science ®Google Scholar
• Laursen TM, Munk-Olsen T, Nordentoft M, Mortensen PB. Increased mortality among patients admitted with major psychiatric disorders: A register-based study comparing mortality in unipolar depressive disorder, bipolar affective disorder, schizoaffective disorder, and schizophrenia. J Clin Psychiatry 2007;68:899–907.
   PubMed Web of Science ®Google Scholar
• Saha S, Chant D, McGrath J. A systematic review of mortality in schizophrenia: Is the differential mortality gap worsening over time? Arch Gen Psychiatry 2007;64:1123–31.
   PubMed Web of Science ®Google Scholar
• Faustman WO, Ringo DL, Faull KF. An association between low levels of 5-HIAA and HVA in cerebrospinal fluid and early mortality in a diagnostically mixed psychiatric sample. Br J Psychiatry 1993;163:519–21.
   PubMed Web of Science ®Google Scholar
• Brown S, Birtwistle J, Roe L, Thompson C. The unhealthy lifestyle of people with schizophrenia. Psychol Med 1999;29: 697–701.
   PubMed Web of Science ®Google Scholar
• Allison DB, Fontaine KR, Heo M, Mentore JL, Cappelleri JC, Chandler LP, . The distribution of body mass index among individuals with and without schizophrenia. J Clin Psychiatry 1999;60:215–20.
   PubMed Web of Science ®Google Scholar
• Mann JJ. Neurobiology of suicidal behaviour. Nat Rev Neurosci 2003;4:819–28.
   PubMed Web of Science ®Google Scholar
• Mann JJ, Waternaux C, Haas GL, Malone KM. Toward a clinical model of suicidal behavior in psychiatric patients. Am J Psychiatry 1999;156:181–9.
   PubMed Web of Science ®Google Scholar
• Brown GL, Linnoila MI. CSF serotonin metabolite (5-HIAA) studies in depression, impulsivity, and violence. J Clin Psychiatry 1990;51 Suppl:31–41; discussion 42–3.
   PubMedGoogle Scholar
• Lidberg L, Belfrage H, Bertilsson L, Evenden MM, Asberg M. Suicide attempts and impulse control disorder are related to low cerebrospinal fluid 5-HIAA in mentally disordered violent offenders. Acta Psychiatr Scand 2000;101:395–402.
   PubMed Web of Science ®Google Scholar
• Placidi GP, Oquendo MA, Malone KM, Huang YY, Ellis SP, Mann JJ. Aggressivity, suicide attempts, and depression: Relationship to cerebrospinal fluid monoamine metabolite levels. Biol Psychiatry 2001;50:783–91.
   PubMed Web of Science ®Google Scholar
• Stanley B, Molcho A, Stanley M, Winchel R, Gameroff MJ, Parsons B, . Association of aggressive behavior with altered serotonergic function in patients who are not suicidal. Am J Psychiatry 2000;157:609–14.
   PubMed Web of Science ®Google Scholar
• Currier D, Mann JJ. Stress, genes and the biology of suicidal behavior. Psychiatr Clin North Am 2008;31:247–69.
   PubMed Web of Science ®Google Scholar
• Carlborg A, Jokinen J, Nordström AL, Jönsson EG, Nordström P. CSF 5-HIAA, attempted suicide and suicide risk in schizophrenia spectrum psychosis. Schizophr Res 2009;112:80–5.
   PubMed Web of Science ®Google Scholar
• Carlborg A, Jokinen J, Nordström AL, Jönsson EG, Nordström P. Attempted suicide predicts suicide risk in schizophrenia spectrum psychosis. Nord J Psychiatry 2009;64:68–72.
   Web of Science ®Google Scholar
• Carlborg A, Jokinen J, Jönsson EG, Nordström AL, Nordström P. Long-term suicide risk in schizophrenia spectrum psychoses: Survival analysis by gender. Arch Suicide Res 2008;12:347–51.
   PubMed Web of Science ®Google Scholar
• Bjerkenstedt L, Gullberg B, Härnryd C, Sedvall G. Monoamine metabolite levels in cerebrospinal fluid of psychotic women treated with melperone or thiothixene. Arch Psychiatr Nervenkr 1977;224:107–18.
   PubMedGoogle Scholar
• Härnryd C, Bjerkenstedt L, Gullberg B, Oxenstierna G, Sedvall G, Wiesel FA. Time course for effects of sulpiride and chlorpromazine on monoamine metabolite and prolactin levels in cerebrospinal fluid from schizophrenic patients. Acta Psychiatr Scand Suppl 1984;311:75–92.
   PubMedGoogle Scholar
• Oxenstierna G, Bergstrand G, Edman G, Flyckt L, Nybäck H, Sedvall G. Increased frequency of aberrant CSF circulation in schizophrenic patients compared to healthy volunteers. Eur Psychiatry 1996;11:16–20.
   PubMed Web of Science ®Google Scholar
• Wode-Helgodt B, Fyrö B, Gullberg B, Sedvall G. Effect of chlorpromazine treatment on monoamine metabolite levels in cerebrospinal fluid of psychotic patients. Acta Psychiatr Scand 1977;56:129–42.
   PubMed Web of Science ®Google Scholar
• Sedvall GC, Wode-Helgodt B. Aberrant monoamine metabolite levels in CSF and family history of schizophrenia. Their relationships in schizophrenic patients. Arch Gen Psychiatry 1980;37:1113–16.
   PubMed Web of Science ®Google Scholar
• Swahn CG, Sandgarde B, Wiesel FA, Sedvall G. Simultaneous determination of the three major monoamine metabolites in brain tissue and body fluids by a mass fragmentographic method. Psychopharmacology (Berl) 1976;48:147–53.
   PubMed Web of Science ®Google Scholar
• National Strategy for Suicide Prevention. Goals and Objectives for Action. Rockville, MD: US Department of Health and Human Services, Public Health Service; 2001.
   Google Scholar
• Ekholm B, Ekholm A, Adolfsson R, Vares M, Ösby U, Sedvall GC, . Evaluation of diagnostic procedures in Swedish patients with schizophrenia and related psychoses. Nord J Psychiatry 2005;59:457–64.
   PubMed Web of Science ®Google Scholar
• Vares M, Ekholm A, Sedvall GC, Hall H, Jönsson EG. Characterization of patients with schizophrenia and related psychoses: Evaluation of different diagnostic procedures. Psychopathology 2006;39:286–95.
   PubMed Web of Science ®Google Scholar
• Pompili M, Amador XF, Girardi P, Harkavy-Friedman J, Harrow M, Kaplan K, . Suicide risk in schizophrenia: Learning from the past to change the future. Ann Gen Psychiatry 2007;6:10.
   PubMedGoogle Scholar
• Mortensen PB, Juel K. Mortality and causes of death in first admitted schizophrenic patients. Br J Psychiatry 1993;163:183–9.
   PubMed Web of Science ®Google Scholar
• Meyer JM, Stahl SM. The metabolic syndrome and schizophrenia. Acta Psychiatr Scand 2009;119:4–14.
   PubMed Web of Science ®Google Scholar
• Glassman AH. Depression and cardiovascular comorbidity. Dialogues Clin Neurosci 2007;9:9–17.
   PubMedGoogle Scholar
• Hansen V, Jacobsen BK, Arnesen E. Cause-specific mortality in psychiatric patients after deinstitutionalisation. Br J Psychiatry 2001;179:438–43.
   PubMed Web of Science ®Google Scholar
• Seeman MV. An outcome measure in schizophrenia: Mortality. Can J Psychiatry 2007;52:55–60.
   PubMed Web of Science ®Google Scholar
• Statistics S. Mean life expectancy for general population 50 years of age 2003–2007. Statistics Sweden 2009.
   Google Scholar
• Leucht S, Burkard T, Henderson J, Maj M, Sartorius N. Physical illness and schizophrenia: A review of the literature. Acta Psychiatr Scand 2007;116:317–33.
   PubMed Web of Science ®Google Scholar